EP 140 Pill - white round, 9mm
Pill with imprint EP 140 is White, Round and has been identified as Glycopyrrolate 2 mg. It is supplied by Excellium Pharmaceutical. Inc.
Glycopyrrolate is used in the treatment of Excessive Salivation; Anesthesia; COPD, Maintenance; Peptic Ulcer and belongs to the drug classes anticholinergic bronchodilators, anticholinergics/antispasmodics. There is no proven risk in humans during pregnancy. Glycopyrrolate 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for EP 140
Glycopyrrolate
- Imprint
- EP 140
- Strength
- 2 mg
- Color
- White
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Anticholinergic bronchodilators, Anticholinergics/antispasmodics
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Excellium Pharmaceutical. Inc.
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
magnesium stearate,
lactose anhydrous,
povidone,
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 64125-0140 | Excellium Pharmaceutical Inc. |
| 42291-0304 | AvKare, Inc. |
More about glycopyrrolate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (18)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: anticholinergic bronchodilators
- Breastfeeding
Patient resources
- Glycopyrrolate drug information
- Glycopyrrolate inhalation
- Glycopyrrolate (Inhalation) (Advanced Reading)
- Glycopyrrolate (Intramuscular, Intravenous) (Advanced Reading)
- Glycopyrrolate (Oral) (Advanced Reading)
Other brands
Robinul, Cuvposa, Robinul Forte, Seebri Neohaler, ... +3 more
Professional resources
- Glycopyrrolate monograph
- Glycopyrrolate Injection (FDA)
- Glycopyrrolate Oral Solution (FDA)
- Glycopyrrolate Tablets (FDA)
Other brands
Robinul, Cuvposa, Seebri Neohaler, Dartisla ODT, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
